EPISODE · Apr 16, 2026 · 4 MIN
今天3分钟我们来聊聊淋巴瘤新曙光：CAR-NK疗法显威力
from 源于细胞BioInsid的个人播客
淋巴瘤早期症状易被误认感冒，化疗无效别绝望！CD30靶向CAR-NK细胞疗法临床试验数据亮眼，复发难治患者整体缓解率92.9%，霍奇金淋巴瘤完全缓解率73%，20个月随访两年总生存率76.2%，11位患者缓解超2年。前往小宇宙评论区与主播互动
Embed this episode
Ready to play
今天3分钟我们来聊聊淋巴瘤新曙光：CAR-NK疗法显威力
0:00
4:21
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of 源于细胞BioInsid的个人播客?
This episode is 4 minutes long.
When was this 源于细胞BioInsid的个人播客 episode published?
This episode was published on April 16, 2026.
Can I download this 源于细胞BioInsid的个人播客 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!